Please login to the form below

Not currently logged in

First biosimilar Humira launches in India

AbbVie to face competition for world’s biggest-selling drug

Private sector on rise in England’s NHS, says BMJ

england flagOne-third of NHS contracts have gone to private providers since healthcare reforms

UCB's $1.53bn generics sale falls through

UCB headquartersAdvent and Avista Capita back away from bid to acquire Kremers Urban due to unanticipated conflict in timing

FDA approves Ipsen drug to treat rare tumours

Ipsen buildingGreen light for Somatuline Depot in cancer of the neuroendocrine system

Novartis' acromegaly therapy cleared by FDA

Novartis buildingSignifor LAR shows superior efficiency to older treatments

NICE recommends Pradaxa in blood clot indication

Boehringer Ingelheim PradaxaBoehringer drug backed to treat and prevent deep vein thrombosis and pulmonary embolism

EMA: Lack of evidence for Ebola treatments

European Medicines Agency (EMA)Not enough data to draw conclusions on effectiveness of experimental drugs

Patent cliff losses set to cost pharma $65bn by 2019

A bottle of pills spilled onto some Euro notesLilly, AZ and Otsuka to be hit hard, says GlobalData

Data transparency in Europe

Will 2015 usher in a new era?

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

Consult is a bespoke data collection service designed to support marketing research clients in meeting those changing, increasingly focused research...

Latest intelligence

Improving Corporate Memory as a Patient Safety Strategy
An article by Lorri Zipperer...
Online Physician Communities
How can pharma innovate in child and TYA cancer?
by Dr Tim Ringrose, M3 (EU)...
Building Marketing Capabilities for Competitive Advantage in 2014 & Beyond: Part 3 - Most Respected Companies for their Marketing Excellence
An insight into the leaders external to the healthcare industry and their views in marketing innovation....